[1]
K. Ibrahim, R. and Y. Al-Hamdani, R. 2023. Comparative Effects of Repaglinide Versus Glibenclamide on Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients. Tikrit Journal of Pharmaceutical Sciences. 8, 1 (Apr. 2023), 22–28. DOI:https://doi.org/10.25130/tjphs.2012.8.1.4.22.28.